Abstract

PHARMACOGNOSTICAL AND PHARMACEUTICAL ANALYSIS OF SHUNTHI PUSHKARMOOLADI VATI

Dr. Archana*, Prof. K. S. Patel, Dr. V. K. Kori, Harisha C. R. and V. J. Shukla

Abstract

Bronchial Asthma is a non-communicable chronic lung disease characterized by the following: airway inflammation, airway obstruction mainly due to muscle spasm associated with mucosal edema and stagnation of the mucus, airway hyper-reactivity to aerobiological and irritants, airway remodeling in uncontrolled Asthma. This disease is more predominant in children and aged population. Ayurveda address it as “Tamaka Shwasa.” There are five kinds of Shwasa: Kshudra, Tamaka, Chhinna, Maha and Urdhava. Tamaka Shwasa is a type of Shwasa Roga affecting the Pranavaha Srotas. In Astang Hridyam, the group of four drugs is mentioned for the management of the Shwasa Roga named as Shunthi Pushkarmooladi Vati Palatability is a main issue in treatment of children so keep it mind the Vati form is prepared which is very easily palatable in children. Till date no published data is available regarding evaluation the effect of Shunthi Pushkarmooladi Vati. Final product was subjected to Phrmacognostical and physico-chemical analysis such as microscopic study, loss on drying, ash value, pH, hardness etc. - Phrmacognostical study showed the presence of contents such as;Stomata of Kantkari, Strach grain of Shunthi, Scleroids of Pushkarmoola etc.Preliminary physico-chemical analysis showed that the loss on drying value was found to be 8.35%, pH 5, Ash value-8.37%, Water soluble extract 18.5% etc. High Performance Thin Layer Chromatography (HPTLC) showed 15and 17 spots at 254nm and 366nm respectively. The present work was carried out to standardize the finished product Shunthi Pushkarmoola in terms of its identity, quality and purity. Pharmacognostical and Physico-chemical observations revealed the specific characters of all active constituents used in the preparation.

Keywords: HPTLC, Pharmacogonosy, Shunthi Pushkarmoola, pharmaceutical, Tamaka Shwasa.